Fibrillin expression and localization in various types of carcinomas of the thyroid gland

Modern Pathology

Volumn 19, Issue 5, 2006, Pages 695-700

  Tseleni Balafouta, Sofia ^a   Gakiopoulou, Hariklia ^a   Fanourakis, Galinos ^a   Voutsinas, Gerassimos ^b   Litsiou, Helen ^a   Sozopoulos, Elias ^a   Balafoutas, Dimitrios ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Institute of Biology   (Greece)

Author keywords

Extracellular matrix; Fibrillin 1; RT PCR; Thyroid carcinomas; Tissue microarray

Indexed keywords

FIBRILLIN 1; GLYCOPROTEIN; MESSENGER RNA; PROTEIN; SCLEROPROTEIN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; EXTRACELLULAR MATRIX; FEMALE; FIBER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; STROMA; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS;

EID: 33646133890     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800578     Document Type: Article

References (23)

1. Koukoulis GK, Patriarca C, Gould VE. Adhesion molecules and tumor metastasis. Hum Pathol 1998;29:889-892.
2. Murphy-Ullrich JE. The de-adhesive activity of matri-cellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 2001;7:785-790.
3. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993;120:577-585.
4. Dubuisson L, Lepreux S, Bioulac-Sage P, et al. Expression and cellular localization of fibrillin-1 in normal and pathological human liver. J Hepatol 2001;34:514-522.
5. Ramirez F, Pereira L. The fibrillins. Int J Biochem Cell Biol 1999;31:255-259.
6. Sakai LY, Keene DR, Glanville RW, et al. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J Biol Chem 1991;266:14763-14770.
7. Mir S, Wheatley HM, Hussels IE, et al. A comparative histologic study of the fibrillin microfibrllar system in the lens capsule of the normal subjects and subjects with Marfan syndrome. Invest Opthalmol Vis Sci 1998;39:84-93.
8. Visconti RP, Barth JL, Keeley FW, et al. Codistribution analysis of elastin and related fibrillar proteins in early vertebrate development. Matrix Biol 2003;22:109-121.
9. Sakamoto H, Broekelmann T, Cheresh DA, et al. Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J Biol Chem 1996;271:4916-4922.
10. D' Arrigo C, Burl S, Withers AP, et al. TGF-β1 binding protein-like molecules of fibrillin-1 and -2 mediate integrin-dependent cell adhesion. Connect Tissue Res 1998;37:29-51.
11. Plaff M, Reinhardt DP, Sakai LY, et al. Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett 1996;384:247-250.
12. Tiedemann K, Batge B, Muller PK, et al. Interactions of fibrillin- 1 with heparin/heparin sulfate, implications for microfibrilar assembly. J Biol Chem 2001;276:36035-36042.
13. Ritty TM, Broekelmann TJ, Werneck CC, et al. Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment. Biochem J 2003;375:425-432.
14. Puiu L, Petrakou E, Apostolidou A, et al. Lack of Fas (APO/CD95) gene structural alterations on transcript variant ratio changes in breast cancer. Cancer Lett 2003;194:91-97.
15. Gabri C, Zurzolo C, Bifulko M, et al. Synthesis of extracellular matrix glycoproteins by a differentiated thyroid epithelial cell line. J Cell Physiol 1988;135:39-46.
16. Miettinen M, Virtanen I. Expression of laminin in thyroid gland and thyroid tumors: an immunohistologic study. Int J Cancer 1984;34:27-30.
17. Kondo T, Nakazawa T, Murata S, et al. Stromal elastosis in papillary thyroid carcinomas. Hum Pathol 2005;36:474-479.
18. Reinhardt DP, Sasaki T, Dzamba BJ, et al. Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J Biol Chem 1996;271:19489-19496.
19. Milewicz DM, Grossfield J, Cao SN, et al. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the marfan syndrome. J Clin Invest 1995;95:2373-2378.
20. Zhang H, Apfelroth SD, Hu W, et al. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 1994;124:855-863.
21. Bhatia A, Blades S, Cambridge G, et al. Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments. Immunology 1998;94:56-63.
22. Tseleni-Balafouta S, Gakiopoulou H, Fanourakis G, et al. Tenascin-c protein expression and mRNA splice variants in thyroid carcinoma. Exp Mol Pathol 2005, Oct 28.
23. Lacroix L, Lazar V, Michiels S, et al. Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations. Am J Pathol 2005;167:223-231.